Dr. Daniel Nadler founded OpenEvidence, an artificial intelligence company backed by Sequoia, Kleiner Perkins, Google, and Nvidia. Independent studies show that more American doctors use OpenEvidence than all other AIs combined. In 2025, Dr. Nadler was named to the TIME100 list of the 100 Most Influential People in global health. Prior to OpenEvidence, while still a Ph.D. student at Harvard, Dr. Nadler founded Kensho Technologies, which became the most valuable artificial intelligence company of the 2010s when it was acquired by S&P Global in 2018.